Regulatory Pathways By Region: A Guide For Early-Phase Trials

Regulatory experts work alongside drug developers from the earliest stages of development planning to help establish a clear, efficient path toward clinical trials and beyond. Through strategic regulatory pathway assessments, gap analyses, and customized development plans, they identify the most suitable route while proactively addressing potential requirements, challenges, and risks.

To support informed decision-making across global regions, this infographic provides a comparative overview of key health authorities and their respective ethics and regulatory submission processes for early-phase clinical trials. By presenting requirements side by side, it offers a concise view of regulatory similarities, differences, and critical considerations, helping sponsors navigate complex international development pathways with greater confidence and clarity.